Alpharma, Inc. develops, manufactures, and markets pharmaceutical products for humans and animals. The company has three business lines: Pharmaceuticals, Active Pharmaceutical Ingredients (API), and Animal Health (AH). Its Pharmaceuticals business markets one branded pharmaceutical prescription product, which is a pain medication sold under the trademark KADIAN in the United States. It also develops an investigational abuse deterrent extended-release morphine product, which is in Phase III clinical trials. The company's API business develops, manufactures, and markets a line of fermentation-based active pharmaceutical ingredients and one chemically synthesized active pharmaceutical...